Physician profile
Matthew D Dellinger
NPI 1538489018
$762.53
in general payments reported to CMS, 2019-2025
11 companies · $259 in 2025
The $259 reported for 2025 was more than what 81% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.95 · 2020: $122 · 2021: $73.25 · 2022: $163 · 2024: $130 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358 · Gift: $31.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.95 |
| Gift | $31.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $196.01 | 2021-2022 | |
| Abbvie INC. | $145.06 | 2025 | |
| Patterson Companies, INC. | $141.82 | 2024-2025 | |
| Align Technology, INC. | $130.81 | 2020-2021 | |
| Carestream Dental, LLC | $31.81 | 2020 | |
| A-Dec, INC. | $31.00 | 2024 | |
| Kulzer, LLC | $25.07 | 2025 | |
| Dentsply Sirona INC | $18.54 | 2025 | Nupro |
| Kerr Corporation | $14.95 | 2019 | |
| Envista Holdings Corporation | $14.24 | 2025 | Herculite Ultra |
| Voco America INC. | $13.22 | 2024 | Voco Profluorid Varnish, Voco Retraction Paste, Meron Plus Qm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.